SecBot SecBot
SC 13G/A ·Filed Nov 3, 2026

CNTB

Connect Biopharma Holdings Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed13d 5h ago SEC0001664985-26-000003
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to Schedule 13D or changes in Qiming's stake; the passive filing suggests no imminent activist activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$0.7805
T+0 close · Nov 3, 2026 · via day close
Latest settled
−11.74%
T+5 · $0.6889 · next T+20 in 16d
Vs SPY
−10.82%
α at T+5
Latest observation
−11.99%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $0.7805entry
  2. T+1 · 12d ago −6.25%α −1.84% · $0.7317
  3. T+5 · 6d ago −11.74%α −10.82% · $0.6889
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Qiming Managing Directors Fund V, L.P. and related Qiming entities filed an amended Schedule 13G disclosing an aggregate beneficial ownership of 2,757,490 ordinary shares (4.4% of shares outstanding as of July 31, 2026) in Connect Biopharma Holdings Ltd, up from a prior stake. The filing reflects a routine passive stake update with no change in investment intent.

Key Financial Metrics

Stake
4.4%
Investor
Qiming Managing Directors Fund V, L.P.

Key Facts

  • Qiming Managing Directors Fund V, L.P. and related entities filed an amended Schedule 13G on November 3, 2026.
  • Aggregate beneficial ownership: 2,757,490 ordinary shares, representing 4.4% of shares outstanding as of July 31, 2026.
  • The filing is an amendment to a prior Schedule 13G, indicating a passive investment stance.
  • The stake is held across multiple Qiming funds: Qiming Venture Partners V, L.P. (1,766,600 shares, 2.8%), Qiming Venture Partners VII, L.P. (926,527 shares, 1.5%), Qiming Managing Directors Fund V, L.P. (54,826 shares, 0.1%), and Qiming VII Strategic Investors Fund, L.P. (8,537 shares, 0.0%).
  • The percentage is based on 62,974,309 ordinary shares outstanding as of July 31, 2026, per the issuer's Form 10-Q.

Financial Impact

Qiming entities hold 4.4% of Connect Biopharma, a passive stake with no stated change in investment intent.

ownership

Risk Factors

  • No material financial data provided in the filing; the stake is passive and routine.
  • No indication of intent to influence management or strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001664985-26-000003
Document: 0001664985-26-000003-index.html0001664985-26-000003
Document: 0001664985-26-000003.txt0001664985-26-000003

Track record

12 reports on CNTB

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.39% at T+20 after the May 12, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $0.5873 Now $0.6430 +9.48% settles Nov 24
  2. Nov 16, 2026today Press Release Neutral 6/10 Entry $0.6430 Now $0.6430 +0.00% settles Nov 24
  3. Nov 3, 202613d ago SC 13G/A Neutral 2/10 Viewing Entry $0.7805 to $0.6889 Now $0.6430 −17.62% ▼ −11.74% −10.82% vs SPY
  4. Oct 6, 20265w ago SC 13G Neutral 3/10 Entry $0.9450 to $0.9090 Now $0.6430 −31.96% ▼ −3.81% −2.83% vs SPY
  5. Sep 30, 20266w ago 8-K Bullish 7/10 Entry $1.10 to $0.9450 Now $0.6430 −41.55% ▼ −14.09% −16.00% vs SPY
  6. Sep 30, 20266w ago Press Release Bullish 7/10 Entry $1.10 to $0.9447 Now $0.6430 −41.55% ▼ −14.12% −16.03% vs SPY
  7. Sep 15, 20268w ago 8-K Mixed 6/10 Entry $1.17 to $1.28 Now $0.6430 −45.04% ▲ +9.40% +8.58% vs SPY
  8. May 12, 202626w ago 8-K Neutral 4/10 No price data
  9. May 12, 202626w ago Press Release Bearish 6/10 Entry $2.68 to $2.38 Now $0.6430 +76.01% ▲ +11.19% +11.27% vs SPY
  10. Apr 23, 202629w ago 8-K Bullish 7/10 Entry $2.52 to $2.53 Now $0.6430 −74.48% ▲ +0.40% −1.08% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026